New insights into erythropoiesis

Current Opinion in Hematology

Volumn 9, Issue 2, 2002, Pages 93-100

  Koury, Mark J ^a,c   Sawyer, Stephen T ^b   Brandt, Stephen J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROID KRUPPEL LIKE FACTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL X; PROTEIN TYROSINE KINASE; RNA; STAT PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NF E2; TYROSINE;

APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL ORGANELLE; EMBRYO DEVELOPMENT; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; SIGNAL TRANSDUCTION;

EID: 0036181782     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200203000-00002     Document Type: Review

References (55)

1. CaM kinase IV regulates lineage commitment and survival of erythroid progenitors in a non-cell-autonomous manner
2. Primitive erythropoiesis in the Xenopus embryo: The synergistic role of LMO-2, SCL and GATA-binding proteins
3. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis
4. Hematopoietic colony-forming cells derived from human embryonic stem cells
5. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro
6. Differentiating embryonal stem cells are a rich source of haemopoietic gene products and suggest erythroid preconditioning of primitive haemopoietic stem cells
7. Erythroid Krüppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice
8. Unanticipated repression function linked to erythroid Krüppel-like factor
9. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL
10. Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice
11. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins
12. mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming uniterythroid development
13. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
14. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor
15. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain
16. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif
17. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis
18. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene
19. Molecular mechanisms of erythropoietin signaling
20. Stat5a and Stat5b proteins have essential and nonessential, or redundant, role in cytokine responses
21. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: A direct role for Stat 5 in Bcl-X(L) induction
22. Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropolesis: Lack of specificity of STAT signals during red blood cell development
23. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT-1 and STAT-5 in erythroid cells
24. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells)
25. Erythroid cells rendered erythropoietin independent by infection with friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: Involvement of insulin receptor substrate-related adapter proteins
26. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells
27. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors
28. A member of forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction
29. Angiotensin II stimulates proliferation of normal early erythroid progenitors
30. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice
31. Induction of megakaryocytic differentiation in primary human erythroblasts: A physiologic basis for leukemic lineage plasticity
32. Fas antigen expression on CD34+ human marrow cells is induced by interferon-gamma and potentiates cytokine-mediated hematopoietic suppression in vitro
33. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell, apoptosis
34. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: Possible role in progenitor survival
35. Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand
36. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis
37. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells
38. An expansion phase precedes terminal erythroid differentiation of hematopoietic progenitor cells from cord blood in vitro and is associated with up-regulation cyclin E and cyclin-dependent kinase 2
39. Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1
40. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors
41. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip 1) and inactivation of cdk2 kinase
42. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism
43. Apoptosis of late stage erythroblasts in megalobiastic anemia: Association with DNA damage and macrocyte production
44. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematepoietic organs
45. Caspase activation is required for terminal erythroid differentiation
46. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: A mechanism for controlled rates of erythrocyte production
47. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver
48. Oxygenation of biologic membranes by the pure reticulocyte lipoxygenases
49. A function for lipoxygenase in programmed organelle degradation
50. Activation of translationally inactive lipoxygenase mRNP particles from rabbit reticulocytes
51. Lipoxygenase mRNA silencing in erythroid differentiation: The 3'UTR regulatory complex controls 60S ribosomal subunit joining
52. The roles of Bcl-xL and apopain in the control of erythropoiesis by erythropoietin
53. Bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation
54. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly
55. Red cell production and kinetics